Navigation Links
September is Leukemia, Lymphoma and Myeloma Awareness Month
Date:9/12/2007

Tremendous advances have been made to treat blood cancer but the battle is

far from won

WHITE PLAINS, N.Y., Sept. 12 /PRNewswire/ -- Remarkable progress has been made in treating patients with blood cancers. Sixty years ago there were few effective treatments for children or adults with blood cancer and the rate of survival was very low. Today, about 75 percent of children with acute leukemia and nearly 80 percent of children and adults with Hodgkin lymphoma are cured. Improved therapies and stem cell transplantation have dramatically improved survival rates for most blood cancers, and even patients with diseases resistant to treatment, such as myeloma, are benefiting from new drugs that are increasing the rate and duration of remissions.

Yet, more than three quarters of a million people in the United States currently have some form of blood cancer. Every ten minutes someone dies from a blood cancer and an estimated 52,310 will die from one this year.

The Leukemia & Lymphoma Society is a beacon of help and guidance to those touched by blood cancer and each September the Society observes Leukemia, Lymphoma and Myeloma Awareness Month, to shed light on these diseases and let the public know that there are resources available for blood cancer patients and their families.

"Awareness Month is an opportunity to increase the public's understanding of blood cancers and encourage people to support the funding of research to find cures and education programs to help patients have the best possible outcomes throughout their cancer experience," said Dwayne Howell, the Society's President and CEO.

Since its inception in 1949, the Society has invested more than $550 million in research to find cures and better therapies, and funded $64.9 million in 2007 alone. The Society supports investigators' efforts to find new molecular targets for treatment and potential immunotherapies, and helps them translate their labo
'/>"/>

SOURCE The Leukemia & Lymphoma Society
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Dasatinib Shows High Early Response Rate as First Treatment for Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
4. Fractionated Radioimmunotherapy With (90)Y-epratuzumab in Non-Hodgkins Lymphoma Appears Safe and Active in a Phase I/II Study
5. Favrille Announces Data From Phase 2 Clinical Trial of FavId for Indolent B-Cell Non-Hodgkins Lymphoma in Europe
6. Gloucester Pharmaceuticals Reports Positive Interim Phase II Data on Romidepsin for T-Cell Lymphomas at the 2007 American Society of Clinical Oncology Annual Meeting
7. Nuvelo Announces Publication of Preclinical Study Results Demonstrating the Potential of NTB-A as a New Target for Leukemia and Lymphomas
8. Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)
9. Phase 2 Clinical Results of Ganite Plus Standard Therapy in Patients with Relapsed/Refractory Lymphoma Presented at ASCO
10. Phase 2 Clinical Results of Ganite Plus Standard Therapy in Patients with Relapsed/Refractory Lymphoma Presented at ASCO
11. MabThera Significantly Extends Survival And Cures More Patients With Aggressive Lymphoma Than Chemotherapy Alone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/9/2008)...cted in November 2008, BOTHELL, Wash., Oct. 9 /PR...DDD ) announced today the completion of patient en...otal trials to evaluate the safety and,efficacy of...ibuprofen for,the over-the-counter (OTC) market. T... this pivotal trial in November 2008. Ibuprofen is...
(Date:10/8/2008)...swire-USNewswire/ -- The facts are,overwhelming. E...,sub-Saharan Africa. More than 35,000,000 women, c...y died of AIDS. The Foundation for Hospices,in Sub... their families,find compassion and relief from su...tnering initiative links African hospices and pall...
(Date:10/8/2008)...rs Research That May Offer New Hope to,Heart Failu...onally, over 3,000 people are,waiting for a heart ...half,of those will receive a transplant. Now, pion...s paving the way for how to treat congestive heart...News Release, go to:, http://www.prnewswire.com/mn...
(Date:10/8/2008)...te TAXUS(R) Element(TM) Platinum Chromium .... 8 /- Boston Scientific,Co...s completed enrollment in,the PERSEUS trial, desig...US(R) Element(TM) paclitaxel-eluting coronary sten...y 1,500 patients at 100 U.S. and,international cen...
Breaking Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 2In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 4Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4New Water Purification Product from Reliance Products and Procter 26 Gamble now Available in Retail Stores 11932 1New Water Purification Product from Reliance Products and Procter 26 Gamble now Available in Retail Stores 11932 2New Water Purification Product from Reliance Products and Procter 26 Gamble now Available in Retail Stores 11932 3LodgeNet Interactive Corporation 2007 Earnings Release and Teleconference Announcement 11927 1LodgeNet Interactive Corporation 2007 Earnings Release and Teleconference Announcement 11927 2Rural Hospital Chooses Microsoft Dynamics GP for Healthy Time and Labor Savings 11925 1Rural Hospital Chooses Microsoft Dynamics GP for Healthy Time and Labor Savings 11925 2Rural Hospital Chooses Microsoft Dynamics GP for Healthy Time and Labor Savings 11925 3Rural Hospital Chooses Microsoft Dynamics GP for Healthy Time and Labor Savings 11925 4NIH report on intracranial stent points out need for upcoming large scale clinical trial 11921 1NIH report on intracranial stent points out need for upcoming large scale clinical trial 11921 2
...e 07, 2007 /PRNewswire-FirstCall/ -,Neurochem (Int...bsidiary of Neurochem Inc. , announces that the Ne... results of the "Eprodisate,For AA Amyloidosis Tri...al in the search for a treatment of AA amyloidosis...or eprodisate,(KIACTA(TM)) demonstrate that this p...
...zonisamide SR as a novel component in,EMPATIC(TM) .../PRNewswire-FirstCall/ -- Orexigen(TM),Therapeutic...he,treatment of central nervous system disorders w...esults from a Phase I trial evaluating,safety and ...ned-release (SR) formulation of zonisamide. In the...
Other Medicine Technology:Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 2Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 3Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 4Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 5OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 2OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 3OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 4
(Date:10/10/2008)...pon the completion of a highly successful CIO Fina...udly announces their next business technology gath...ogy executives in healthcare. CDM Media has confir...2, 2009 at the Four Seasons Resort in Scottsdale, ...) October 11, 2008 -- Upon the completion of a hig...
(Date:10/10/2008)...lif., Oct. 10 /PRNewswire/ -- A senior citizen,soa...ntains in a small,plane. The high-flying adventure...The thrill came from a last-wish program through S...or Living, where Heden was a patient.,Called Go Wi... has helped,many realize a special activity at the...
(Date:10/10/2008)...n could lessen long-term side effects, study finds...- Using chemotherapy alone, and delaying or avoidi...ing children with inoperable or progressive low-gr...itutional study. , Low-grade glioma is the most... performed, the survival rate for patients is 95 p...
(Date:10/10/2008)...alth (NIH) scientists have identified a protein th... blood cells, T and B cells, enabling them to inte...-lasting immunity after an infection. Their findi...a genetic defect that prevents them from making th...with a common virus that otherwise is rarely fatal...
Breaking Medicine News(10 mins):Health News:CIO Healthcare Summit Announces Dates and VIP Delegates 2Health News:Deck of Cards is More Than a Game: Integral in Silverado Hospice Care 2Health News:Chemo Alone Effective in Treating Kids' Brain Tumors 2Health News:NIH scientists discover crucial control in long-lasting immunity 2Health News:NIH scientists discover crucial control in long-lasting immunity 3
...lhi, June 1: The apex consumer court in New Delhi ...mpensation case of claim that was filed by an Indi... his wife in 1998, which he alleged due to the wro...rom Ohio Saha said that the judgement of the Natio...
...y on manslaughter by doctors in UK, says that many...n named Steven Walker was found to be convicted //...found that conviction was low. Due to vengeance a... Hospital researchers found 85 doctors had been ch...
...ndition of Rahul Mahajan, son of late BJP leader P...s admitted to a private hopital here in the wee ho... brought in dead. 'Rahul's condition is serious bu...ametres are functioning normally', Apollo hospital...
...lhi. The National Consumer Commission today dismis... 143 Crores filed by a US-based doctor //who had a...ven at a Kolkata hospital. The National Consumer D...prising Justice M B Shah, Justice K S Gupta and Me...
Other Medicine News:Health News:Court Dismisses 143-Crore Claim Against Hospital In Kolkata For Alleged Negligence In Treatment 2Health News:Court Dismisses 143-Crore Claim Against Hospital In Kolkata For Alleged Negligence In Treatment 3
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
Medicine Products: